Osmotica pharmaceuticals plc (OSMT)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-3,083

-26,640

-113,406

-124,167

-6,687

-107,005

-3,955

5,888

-4,607

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

5,562

6,409

14,613

17,998

17,993

20,249

20,456

20,452

20,414

Share compensation

1,107

1,100

1,335

1,326

1,169

-

-

-

-

Deferred income tax benefit

829

-

-

-

-1,060

-

-

-

-

Deferred income tax benefit

-

-

-

-

-

-

-3,198

-1,013

-3,295

Loss on sale of fixed and leased assets

3

-97

-21

-0

-53

-

-

-

-

Bad debt provision

29

-3

-3

-73

-84

-477

-1,053

-139

-99

Amortization of deferred financing and loan origination fees

333

337

343

333

323

391

421

424

414

Change in operating assets and liabilities:
Trade accounts receivable, net

-11,242

10,048

-34,283

11,183

378

-16,779

10,708

-139

23,251

Inventories, net

-769

-5,934

-635

60

3,432

-1,211

-431

2,474

6,604

Prepaid expenses and other current assets

-891

3,359

-6,012

-1,832

-4,691

-3,737

4,988

-2,700

-3,100

Other non‑current assets

18

-

-

-

-

-

-

-

271

Trade accounts payable

289

-1,410

-9,011

-1,674

-4,279

-2,262

-3,643

-37,602

32,182

Accrued and other current liabilities

-18,011

-3,309

-9,264

2,678

-14,436

4,797

7,280

4,198

-10,879

Net cash used in operating activities

-64

675

37,051

1,967

-6,127

30,383

7,228

-7,155

7,101

CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from sale of fixed and leased assets

4

-

-

-

-

-

-

-

-

Payments on disposal of leased assets

1

-

-

-

-

-

-

-

-

Purchase of property, plant and equipment

949

920

951

1,456

635

1,145

816

744

1,436

Net cash used in investing activities

-946

-955

-973

-1,456

-635

-1,145

-806

-744

-1,436

CASH FLOWS FROM FINANCING ACTIVITIES:
Payments to affiliates

-

-

-

-

-

-0

0

0

2

Payments on finance lease obligations, ASC842

33

32

33

32

31

-

-

-

-

Payments on finance lease obligations, ASC840

-

-

-

-

-

30

27

27

27

Proceeds from public offering, net of issuance costs

31,791

-

-

-

-

-

-

-

-

Debt repayment

-

-

-

-

-

49,999

2,046

2,046

2,046

Repurchases of ordinary shares

167

-

-

-

-

-

-

-

-

Payments for taxes related to net share settlement of equity awards

616

-

-

-

-

-

-

-

-

Repayment of insurance financing loan

-

397

593

1,117

979

-

-

-

-

Net cash provided by (used in) financing activities

30,975

-1,879

-1,965

163

-1,010

9,337

-2,363

-1,294

-2,075

Net change in cash and cash equivalents

29,965

-2,159

34,113

674

-7,772

38,575

4,057

-9,194

3,589

Effect on cash of changes in exchange rate

-

-

-

-

-

55

-263

-591

-138

Supplemental disclosure of cash and non‑cash transactions:
Cash paid for interest

5,375

3,978

2,930

4,202

4,069

5,108

4,840

4,856

4,813

Cash paid for taxes

474

745

179

150

215

1,926

446

171

94